• Clinical trials in pediatric ALS: a TRICALS feasibility study 

      Kliest, Tessa; van Eijk, Ruben P. A.; Al-Chalabi, Ammar; Albanese, Alberto; Andersen, Peter M.; Amador, Maria Del Mar; Bråthen, Geir; Brunaud-Danel, Veronique; Brylev, Lev; Camu, William; de Carvalho, Mamede; Cereda, Cristina; Cetin, Hakan; Chaverri, Delia; Chiò, Adriano; Corcia, Philippe; Couratier, Philippe; De Marchi, Fabiola; Desnuelle, Claude; van Es, Michael A.; Esteban, Jesús; Filosto, Massimiliano; Redondo, Alberto García; Grosskreutz, Julian; Hanemann, Clemens O.; Holmøy, Trygve; Høyer, Helle; Ingre, Caroline; Koritnik, Blaz; Kuzma-Kozakiewicz, Magdalena; Lambert, Thomas; Leigh, Peter N.; Lunetta, Christian; Mandrioli, Jessica; McDermott, Christopher J.; Meyer, Thomas; Mora, Jesus S.; Petri, Susanne; Povedano, Mónica; Reviers, Evy; Riva, Nilo; Roes, Kit C. B.; Rubio, Miguel Á.; Salachas, François; Sarafov, Stayko; Sorarù, Gianni; Stevic, Zorica; Svenstrup, Kirsten; Møller, Anette Torvin; Turner, Martin R.; Van Damme, Philip; van Leeuwen, Lucie A. G.; Varona, Luis; Costa, Juan F. Vázquez; Weber, Markus; Hardiman, Orla; Berg, Leonard H. van den (Peer reviewed; Journal article, 2022)
      Clinical trials in pediatric ALS: a TRICALS feasibility study
    • Genetic epidemiology of amyotrophic lateral sclerosis in Norway - a 2-year population based study 

      Olsen, Cathrine Goberg; Busk, Øyvind Løvold; Aanjesen, Tori Navestad; Alstadhaug, Karl Bjørnar; Bjørnå, Ingrid Kristine; Braathen, Geir Julius; Breivik, Kristin Lif; Demic, Natasha; Flemmen, Heidi Øyen; Hallerstig, Erika; HogenEsch, Ineke; Holla, Øystein Lunde; Jøntvedt, Anne Berit; Kampman, Margitta T.; Kleveland, Grethe; Kvernmo, Helene Ballo; Ljøstad, Unn; Maniaol, Angelina; Morsund, Åse Hagen; Nakken, Ola; Novy, Camilla; Rekand, Tiina; Schlüter, Katrin Ruth; Schuler, Stephan; Tveten, Kristian; Tysnes, Ole-Bjørn; Holmøy, Trygve; Høyer, Helle (Peer reviewed; Journal article, 2022)
      Background: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that affects motor neurons. In Europe, disease-causing genetic variants have been identified in 40-70% of familial ALS patients and approximately ...